New knowledge on EphB signaling may improve treatment of intestinal cancers
[PRESS RELEASE 4/2/2015] A new study led by researchers at Sweden’s Karolinska Institutet and Nanyang Technological University in Singapore, provides experimental evidence that a drug that inhibits the EphB-signaling pathway in the cell effectively can suppress the development of intestinal tumors. According to the investigators, this knowledge may be important in the design of new treatments for abrogating adenoma formation and cancer progression in patients predisposed to develop colorectal cancer.Colorectal cancer is one of the three most common cancers worldwide and almost 95 percent of